Visit CCMB's Official Website

His remarks come in the backdrop of Russian President Vladimir Putin’s announcement that his country has developed the world’s first vaccine against coronavirus.

The efficacy and safety levels of the vaccine developed by Russia for treating COVID-19 patients is not predictable in the absence of data, a top official of the CSIR-Centre for Cellular and Molecular Biology said on Wednesday.

His remarks come in the backdrop of Russian President Vladimir Putin’s announcement that his country has developed the world’s first vaccine against coronavirus.

Director of CCMB, Rakesh K Mishra said if people are “lucky” then the Russian vaccine will work.

“Both efficacy and safety of the vaccine are still unknown. They haven’t conducted proper trials, which is stage-III trials. That is when you get to know the efficacy, when it is tested on a large number of people and should wait for two months to see whether they get a viral infection or not. Doesn’t look like they have carried out (large scale testings) because if you have done it, then show us the data. You cannot keep it confidential,” Mishra told PTI.

He noted that the vaccine ought to be carefully evaluated before it goes to people and any country or company not releasing the data with respect to vaccine was bad.

Read more at: https://www.moneycontrol.com/news/india/sans-proper-data-russian-covid-19-vaccines-efficacy-safety-unknown-ccmb-chief-5689261.html